New 64Cu PET imaging agents for personalised medicine and drug development using the hexa-aza cage, SarAr
- PMID: 17036125
- DOI: 10.1039/b605615f
New 64Cu PET imaging agents for personalised medicine and drug development using the hexa-aza cage, SarAr
Abstract
The success of positron emission tomography (PET) in personalised medicine and drug development requires radioisotopes that provide high quality images and flexible chemistry for a broad application. 64Cu is arguably one of the most suitable PET isotopes for imaging with the evolving target agents, but there are not many appropriate chelating agents for 64Cu and this has limited its wider application. The bi-functional chelator, SarAr is known to bind 64Cu2+ quantitatively (i.e. one metal per ligand present) and rapidly (<2 min) at 10(-6) M over a range of pH (4-9). In this paper the conjugation of SarAr to the whole and fragmented antibody is described. Conjugation of the SarAr to the protein does not impair its coordination of the 64Cu. It complexes the 64Cu2+ rapidly, quantitatively and essentially irreversibly at pH 5. Animal studies show that the 64Cu-SarAr-immunoconjugates maintain their specificity for the target and are stable in vivo. Also, SarAr is a platform technology, is easy to use in a kit formulation and is readily adaptable for the wider application in 64Cu PET imaging.
Similar articles
-
Sarar technology for the application of Copper-64 in biology and materials science.Q J Nucl Med Mol Imaging. 2008 Jun;52(2):193-202. Epub 2008 Jan 5. Q J Nucl Med Mol Imaging. 2008. PMID: 18174877 Review.
-
Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates.Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17489-93. doi: 10.1073/pnas.0708436104. Epub 2007 Oct 22. Proc Natl Acad Sci U S A. 2007. PMID: 17954911 Free PMC article.
-
Synthesis of hexa aza cages, SarAr-NCS and AmBaSar and a study of their metal complexation, conjugation to nanomaterials and proteins for application in radioimaging and therapy.Dalton Trans. 2013 Oct 28;42(40):14402-10. doi: 10.1039/c3dt51199e. Dalton Trans. 2013. PMID: 23851350
-
In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.J Nucl Med. 2007 Aug;48(8):1327-37. doi: 10.2967/jnumed.107.039487. Epub 2007 Jul 13. J Nucl Med. 2007. PMID: 17631556
-
Matching chelators to radiometals for radiopharmaceuticals.Chem Soc Rev. 2014 Jan 7;43(1):260-90. doi: 10.1039/c3cs60304k. Epub 2013 Oct 30. Chem Soc Rev. 2014. PMID: 24173525 Review.
Cited by
-
Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals.J Labelled Comp Radiopharm. 2014 Apr;57(4):224-30. doi: 10.1002/jlcr.3165. Epub 2013 Dec 18. J Labelled Comp Radiopharm. 2014. PMID: 24347474 Free PMC article. Review.
-
ImmunoPET: Concept, Design, and Applications.Chem Rev. 2020 Apr 22;120(8):3787-3851. doi: 10.1021/acs.chemrev.9b00738. Epub 2020 Mar 23. Chem Rev. 2020. PMID: 32202104 Free PMC article. Review.
-
Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with 64Cu Using NOTA and NODAGA.Contrast Media Mol Imaging. 2017 Feb 28;2017:8565802. doi: 10.1155/2017/8565802. eCollection 2017. Contrast Media Mol Imaging. 2017. PMID: 29097939 Free PMC article.
-
Multiagent imaging of inflammation and infection with radionuclides.Clin Transl Imaging. 2013;1(6):385-396. doi: 10.1007/s40336-013-0041-z. Epub 2013 Nov 23. Clin Transl Imaging. 2013. PMID: 32289033 Free PMC article. Review.
-
Imaging fibrosis in inflammatory diseases: targeting the exposed extracellular matrix.Theranostics. 2019 Apr 13;9(10):2868-2881. doi: 10.7150/thno.28892. eCollection 2019. Theranostics. 2019. PMID: 31244929 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
